References

Discover epigenomic biomarkers with efficiency using Guardant Infinity methylation technology.¹

Plasma-based methylation sequencing is now easily scalable—from research to the clinic.¹

Molecular recovery of Guardant Infinity methylation technology compared with bisulfite methods.¹

ctDNA, circulating tumor DNA.

Improve sensitivity and efficiency over bisulfite methods through better epigenomic coverage.¹

Increase sensitivity in ctDNA detection with up to 1300% greater molecular recovery.¹